Iceland· IS-EU/1/16/1094/001
Ninlaro
A ixazomib product containing ixazomibum inn cítrat, registered in Iceland by Takeda Pharma A/S. The same ATC class is registered in 13 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Ixazomib is registered in 13 of 19 countries.
Countries holding a registration under ATC L01XG03 (ixazomib), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 8 of them publish a price we can compare per daily dose
Ixazomib · ATC L01XG03
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ixazomib costs, country by country.
Normalised to the WHO defined daily dose (0.43 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ixazomib · price per daily dose (0.43 mg)
USD · FX 28 Sept 2026
- CH Switzerland$395.98
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Ixazomibum INN cítrat
- Manufacturer
- Takeda Pharma A/S
- Country
- Iceland (IS)
- ATC code
- L01XG03
- ATC class
- Ixazomib
- Defined daily dose
- 0.43 mg, O
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean5908251 stk x3 þpakkiISK 944548
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
226 interactions on record for ixazomib.
Graded by severity as the source publishes them — 45 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ixazomib · interactions on record
226 records
- 45 severe
- 181 moderate
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- RifampicinJ04AB02severe
- RifabutinJ04AB04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ixazomib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomIxazomib 2.3mg capsulesTakeda UK Ltd
- United StatesNINLAROTakeda Pharmaceuticals America, Inc.
- SwitzerlandNinlaro 2.3 mg, HartkapselnTakeda Pharma AG
- CzechiaNINLAROTakeda Pharma A/S, Vallensbaek Strand
- SpainNINLARO 2,3 MG CAPSULAS DURASTakeda Pharma A/S
- FinlandNINLAROTakeda Pharma A/S
- FranceNINLARO 2,3 mg, géluleTAKEDA PHARMA (DANEMARK)
- CanadaNINLAROTAKEDA CANADA INC
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Ninlaro
- Norway · Ninlaro
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ad701159-9a4e-4dd1-be38-2dd917a15a8b GET /v1/drugs/ad701159-9a4e-4dd1-be38-2dd917a15a8b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Hart hylki",
"source": "lyfjastofnun",
"atc_raw": "L01XG03",
"marketed": true,
"strength": "2,3 mg",
"ma_number": "EU/1/16/1094/001",
"substance": "Ixazomibum INN cítrat",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í blóðsjúkdómum.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "42695"
}See everything about ixazomib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.